Back to top

BTIG Sticks to Its Buy Rating for GeneDx Holdings (WGS)

In a report released yesterday, Mark Massaro from BTIG reiterated a Buy rating on GeneDx Holdings, with a price target of $90.00. The company’s sha...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

GeneDx Holdings Corp. (WGS)